{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:20:03Z","timestamp":1786990803588,"version":"build-2736575974"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T00:00:00Z","timestamp":1522195200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ijwd.2018.03.007","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T19:20:47Z","timestamp":1525375247000},"page":"166-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Pemphigoid gestationis and intravenous immunoglobulin therapy"],"prefix":"10.1097","volume":"4","author":[{"given":"Anes","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Uhlenhake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dedee F.","family":"Murrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"10.1016\/j.ijwd.2018.03.007_bb0005","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-4632.2011.04946.x","article-title":"Spectrum of autoimmune bullous diseases in Iran: A 10-year review","volume":"51","author":"Daneshpazhooh","year":"2012","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2018.03.007_bb0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-0960.2011.00854.x","article-title":"Successful treatment of a severe persistent case of pemphigoid gestationis with antepartum and postpartum intravenous immunoglobulin followed by azathioprine","volume":"53","author":"Gan","year":"2012","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1016\/j.ijwd.2018.03.007_bb0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.matbio.2007.10.007","article-title":"Pemphigoid gestationis autoantigen, transmembrane collagen XVII, promotes the migration of cytotrophoblastic cells of placenta and is a structural component of fetal membranes","volume":"27","author":"Huilaja","year":"2008","journal-title":"Matrix Biol"},{"issue":"7","key":"10.1016\/j.ijwd.2018.03.007_bb0020","first-page":"843","article-title":"Elevated serum levels of BP180 antibodies in the first trimester of pregnancy precede gestational pemphigoid and remain elevated for a long time after remission of the disease","volume":"95","author":"Huilaja","year":"2015","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.ijwd.2018.03.007_bb0025","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.det.2011.06.013","article-title":"Pemphigoid gestationis: Current management","volume":"29","author":"Intong","year":"2011","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1016\/j.ijwd.2018.03.007_bb0030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.det.2011.03.002","article-title":"Pemphigoid gestationis: Pathogenesis and clinical features","volume":"29","author":"Intong","year":"2011","journal-title":"Dermatol Clin"},{"issue":"4","key":"10.1016\/j.ijwd.2018.03.007_bb0035","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1046\/j.1365-2230.1999.00472.x","article-title":"Clinical features and management of 87 patients with pemphigoid gestationis","volume":"24","author":"Jenkins","year":"1999","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"10.1016\/j.ijwd.2018.03.007_bb0040","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/archderm.1977.01640080071010","article-title":"Immunopathologic study of herpes gestationis in mother and infant","volume":"113","author":"Katz","year":"1977","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2018.03.007_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2015.02.038","article-title":"Positive clinical outcome with IVIg as monotherapy in recurrent pemphigoid gestationis","volume":"26","author":"Nguyen","year":"2015","journal-title":"Int Immunopharmacol"},{"issue":"9863","key":"10.1016\/j.ijwd.2018.03.007_bb0050","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ijwd.2018.03.007_bb0055","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/j.1471-0528.2002.01016.x","article-title":"Pemphigoid gestationis: New insights into the pathogenesis lead to novel diagnostic tools","volume":"109","author":"Shimanovich","year":"2002","journal-title":"BJOG"},{"issue":"11","key":"10.1016\/j.ijwd.2018.03.007_bb0060","first-page":"699","article-title":"Pemphigo\u00efde gestationnelle post-abortum","volume":"3751","author":"Tbatoua","year":"2012","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.ijwd.2018.03.007_bb0065","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2018.03.007_bb0070","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2340\/00015555-2473","article-title":"The reliability, validity and responsiveness of two disease scores (BPDAI and ABSIS) for bullous pemphigoid: Which one to use?","volume":"97","author":"Wijayanti","year":"2017","journal-title":"Acta Derm Venereol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647518300182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647518300182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T09:26:54Z","timestamp":1641547614000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647518300182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2352647518300182"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2018.03.007","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pemphigoid gestationis and intravenous immunoglobulin therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2018.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}